These conflicting results may be due to the different timing of sampling across studies: in the early stage of stroke (within 24 h after the onset of symptoms), ET-1 levels were increased, as in our study, whereas they were reported to be normal if the sampling was performed after 24 h. This evidence concerns the gene EDN1 and Stroke.